Wednesday, January 10, 2024 1:43:51 PM
I do like many of the boards HIGHER SHARE PRICE SPECULATIONS INDEED!!! =)
MY 2024 F.S. PREDICTION of Average Annual Gross Revenue Before OPEX
(ALL SPECULATION & GUESSING ON MY PART)
Sc2O3 - $355,368,421
Nb - $226,458,000 -(An 8% increase)
The pricing for Titanium Dioxide varies greatly. Given Niocorp only quoted .99 (2022 F.S.) I am using a price point of $200/mt of the quoted pricing below:
800,000,000kg / 2,204kg = 362,976 mt x $200 = $72,595,281
Titanium Concentrate (TiO2=46%) price historical Data
https://www.metal.com/Titanium/202007280003
What Niocorp intends to produce "TRICKLE" SPONGE GRADE & maybe other grades as well has a price point of @$1,100/mt +/- (Very interesting indeed) 362,976 mt x $1,000 = $362,976,000 Oh my! ....
But I'll Use:
(TiO2=46%) - $72,595,281
Viable Rare Earths T.B.D.
My guess will produce the following when compared to MP materials & 3 other U.S. projects (& This could be low!) :
600 tons per year Ny/Pr = 600,000kg x $173 = $103,800,000 (not far off Grunt's estimate!)
24 tons per year of Tr = 24,000kg x $2,383 = $57,320,000
120 tons per year of Dy = 120,000kg x $495 = $59,400,000
Total REE annual value prior to OPEX = $220,392,000 Million
~ & I THINK Niocorp's numbers for Dy & Tr might be a touch more! 30mt & 170mt respectively???~
Viable Rare Earths T.B.D. = $220,392,000
Average Annual Gross Revenue
Sc2O3 - $355,368,421 or 41%
Nb - $226,458,000 or 26%
TiO2=46% - $72,595,281 or 8%
Viable Rare Earths - $220,392,000 or 25%
Total Average Annual Gross Revenue = $874,813,702
IF YOU TAKE AWAY ALL THE SCANDIUM = $519,445,281
IF YOU ONLY PRICE THE SCANDIUM Half Value = $697,129,492
PLUS YOU HAVE BYPRODUCTS CaCO3 & MgCO3 - If you do some D.D. you might do a happy dance as these are not too shabby either & they will have ALOT OF IT! Probably close to TITANIUM Tonnage? (All Speculation & GUESSING ABOVE on my part of course!)
HENCE I STILL STAND BY MY CALL OF Niocorp "Could" now push earnings to $600 to $700Million/year
FORM YOUR OWN OPINIONS & CONCLUSIONS ABOVE:
I posted my $24/share price back in mid 2022.~(Hoping for an under-estimate & over-deliver option! lol) ~ My speculations of future share price are indeed very "conservative at $24 to $31 once in production"! Before the R.S. (@ 2027 IF they get Financed in 2024 & start)
I too can see/speculate much higher than $24/share once in production. What I would like to know is WHY did Niocorp finance/pay for the Edison Report using the OLD 2022 F.S. when an EARLY 2024 F.S. is just around the corner? With all the NEW & Improved Economics!???? I did send an email to Jim about that...
Waiting with many
Chico
Recent NB News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 04:28:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:02:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:01:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:01:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:00:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:00:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 09:00:27 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 12/21/2023 09:45:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:55:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 09:30:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 09:30:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 09:30:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 12:30:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2023 09:01:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 12:30:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 12:30:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:30:22 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM